Eulerpool Data & Analytics AQUILAE CLO II PUBLIC LIMITED COMPANY
DUBLIN, IE

名称

AQUILAE CLO II PUBLIC LIMITED COMPANY

地址 / 总部

AQUILAE CLO II PUBLIC LIMITED COMPANY
6TH FLOOR PINNACLE 2
EASTPOINT BUSINESS PARK
CLONTARF
D03 P580 DUBLIN

Legal Entity Identifier (LEI)

2138009VSHCVGQV12E36

Legal Operating Unit (LOU)

213800WAVVOPS85N2205

注册号

412944

公司类型

VYAX

公司类别

普通

状态

LAPSED

验证状态

完全确认

最后更新

下次续订

Eulerpool API
AQUILAE CLO II PUBLIC LIMITED COMPANY 营业额、利润、财务报表、专利、员工等信息
DUBLIN, IE

{ "lei": "2138009VSHCVGQV12E36", "legal_jurisdiction": "IE", "legal_name": "AQUILAE CLO II PUBLIC LIMITED COMPANY", "entity_category": "GENERAL", "entity_legal_form_code": "VYAX", "legal_first_address_line": "6TH FLOOR PINNACLE 2", "legal_additional_address_line": "EASTPOINT BUSINESS PARK, CLONTARF", "legal_city": "DUBLIN", "legal_postal_code": "D03 P580", "headquarters_first_address_line": "6TH FLOOR PINNACLE 2", "headquarters_additional_address_line": "EASTPOINT BUSINESS PARK, CLONTARF", "headquarters_city": "DUBLIN", "headquarters_postal_code": "D03 P580", "registration_authority_entity_id": "412944", "next_renewal_date": "2018-12-06T00:00:00.000Z", "last_update_date": "2019-07-05T08:50:47.290Z", "managing_lou": "213800WAVVOPS85N2205", "registration_status": "LAPSED", "validation_sources": "FULLY_CORROBORATED", "reporting_exception": "", "slug": "AQUILAE CLO II PUBLIC LIMITED COMPANY,DUBLIN,412944" }

Data & Analytics

Eulerpool Private Markets 是私人公司结构化信息的市场领导者。

探索官方发布作为经济信息宝库的价值。Eulerpool Data Service将这些文件研究中的高度手动劳动转变为一种高效解决方案。我们提供经过策判的信息以便自动处理或无缝集成到您的软件中。了解我们的多样化客户群,并探索我们的数据包是如何支持一系列应用的。

Eulerpool 私募市场数据库

  • 通过Data API获取结构化公司信息,通过Widget API进行可视化,并提供季度订阅的导出选项。
  • 一个有吸引力价格的特别入门套餐。
  • 访问超过5800万家公司和超过5.3亿份公开信息的数据。
  • 每日数据更新,覆盖多个国家。
  • 全面的公司数据包括历史记录。
  • 深入的数据分析,涵盖财务、市场营销和技术指标。
  • 完整且透明的来源标注。
  • 强大的搜索功能和容错匹配。
  • 数据通过HTTPS以JSON或XML格式提供。
  • 使用JavaScript进行直观的数据可视化。

每月500美元起即可享受无限访问权限。让我们来谈谈吧!

Eulerpool Data Service
同一法域内的其他公司

SMART DEFENCE SINGLE STRATEGY FINECO AM FUND I

NASH VENTURES LIMITED

TCI REP INTERNATIONAL FUND II

Sogema Investments Limited

BlackRock ESG Multi-Asset Conservative Portfolio UCITS ETF

J.P. MORGAN MANSART EUROPEAN PUT WRITE STRATEGY FUND

LIABILITY AWARE REAL UNLEVERAGED PROFILE FUND

Lily O'Briens Holding Limited

Ardlis Investments Limited

Hyland Kenrick Investments Ltd

SEI DYNAMIC FACTOR ALLOCATION FUND

PRINCIPAL GLOBAL OPPORTUNITIES SERIES PUBLIC LIMITED COMPANY - POST CREDIT OPPORTUNITIES FUND

ABBOTT LABORATORIES VASCULAR ENTERPRISES

CROWN GLOBAL SECONDARIES IV PUBLIC LIMITED COMPANY

FEDERATED HERMES UNCONSTRAINED CREDIT FUND

FLF III-IV MA-CRPTF SUBSIDIARY FINANCE DESIGNATED ACTIVITY COMPANY

Harrells Electrical Contracting Limited

Agile Networks Limited

MOGALL LIMITED

REPLICA PARTNER HOLDING LIMITED

INVESCO NASDAQ BIOTECH UCITS ETF

Asset Management Exchange UCITS CCF

INVESCO STOXX EUROPE 600 OPTIMISED MEDIA UCITS ETF

AMUNDI S&P GLOBAL UTILITIES ESG UCITS ETF

IA Capital Structures (Ireland) PLC

ELEKTRA PURCHASE NO. 78 DESIGNATED ACTIVITY COMPANY

BLACKROCK EUROPEAN CLO IX DESIGNATED ACTIVITY COMPANY

Sanlam Universal Funds plc - Sanlam P2strategies Emerging Market Fund

Global Sovereign Credit

Davy Charitable Foundation Services

EDINBURGH PARTNERS OPPORTUNITIES FUND PLC - EDINBURGH PARTNERS WORLDWIDE OPPORTUNITIES FUND

LIABILITY AWARE NOMINAL UNLEVERAGED PROFILE FUND

BEYOND RIGHTS DISTRIBUTION LIMITED

Motorgeek

O. T. Investments Ltd

FEDERATED HERMES IMPACT OPPORTUNITIES EQUITY FUND

CARRIER TREASURY SERVICES IRELAND LIMITED

KYNDRYL TREASURY SERVICES DESIGNATED ACTIVITY COMPANY

BRENDAN KELLY EXECUTIVE PENSION SCHEME

EUROSKANDIC LIMITED

CABEI Central American Bond Fund

Arcade Finance p.l.c. 2014-185 Life MIP World Stocks Comfort Booster 4

AXA IM Natural Capital Feeder Fund

JPMorgan ETFS (Ireland) ICAV - BetaBuilders US Treasury Bond 0-1 yr UCITS ETF

SHENKMAN CREDIT FUND PLC - SHENKMAN GLOBAL HIGH YIELD BOND FUND

The National Dairy Council

CIREF BERLIN 1 LIMITED

Gainsborough Investment Holdings Limited

EQUATOR INVESTMENT PROGRAMMES - UNITED KINGDOM SPECIALIST EQUITY PROGRAMME

PFIZER IRELAND PHARMACEUTICALS